Osteoporosis, a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration, is a significant public health concern. With the aging population, the prevalence of osteoporosis is expected to increase. This article provides an overview of the advancements in the management of osteoporosis, focusing on recent therapeutic options and diagnostic tools.
New imaging techniques have revolutionized the diagnosis of osteoporosis. High-resolution peripheral quantitative computed tomography (HR-pQCT) provides detailed images of the bone microarchitecture, enhancing the prediction of fracture risk. Trabecular bone score (TBS), a texture parameter that evaluates pixel grey-level variations in lumbar spine dual-energy X-ray absorptiometry (DXA) images, is another promising tool that provides additional information about bone quality.
Recent years have witnessed the emergence of novel pharmacological treatments. Anti-sclerostin antibodies, such as romosozumab, increase bone formation and decrease bone resorption, showing a significant reduction in vertebral and non-vertebral fractures. Anabolic agents like Teriparatide and Abaloparatide stimulate bone formation, offering another therapeutic avenue. Moreover, Denosumab, a RANKL inhibitor, has demonstrated superior efficacy in increasing bone mineral density (BMD) and reducing fracture risk.
Non-pharmacological interventions remain integral to osteoporosis management. These include lifestyle modifications such as adequate calcium and vitamin D intake, regular weight-bearing exercise, smoking cessation, and limiting alcohol intake. Furthermore, fall prevention strategies are vital in reducing fracture risk in this population.
The landscape of osteoporosis management is rapidly evolving, with advancements in both diagnostic tools and therapeutic options. These innovations promise a more comprehensive and personalized approach to osteoporosis care. Healthcare professionals need to stay updated with these advancements to optimize patient outcomes and reduce the burden of this debilitating disease.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation